Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Interest Income | 87,504 | 81,626 | 77,240 | 73,391 | 55,895 |
| Interest Expense | 35,302 | 31,425 | 28,516 | 27,702 | 21,914 |
| Interest Income (Net of Interest Expense) | 52,202 | 50,201 | 48,724 | 45,689 | 33,981 |
| Non-Interest Income | 10,425 | 12,667 | 11,809 | 12,898 | 8,541 |
| Sales | 62,627 | 62,868 | 60,533 | 58,587 | 42,522 |
| Credit Losses Provision | 3,300 | 3,000 | 3,000 | 2,850 | 2,850 |
| Non Interest Expenses | 36,993 | 36,570 | 37,088 | 37,719 | 25,894 |
| Pre-tax Income | 22,334 | 23,298 | 20,445 | 18,018 | 13,778 |
| Income Tax | 6,806 | 7,988 | 6,962 | 6,034 | 4,790 |
| Other Income | 57,636 | 54,723 | 48,961 | 45,720 | 35,692 |
| Net Income | $15,528 | $15,310 | $13,483 | $11,984 | $8,988 |
| EPS Basic Continuous Ops | 29.87 | 29.61 | 26.18 | 23.51 | 24.21 |
| EPS Basic Total Ops | 29.61 | 29.61 | 26.32 | 23.68 | 23.46 |
| EPS Diluted Continuous Ops | 29.22 | 29.01 | 25.60 | 22.90 | 23.54 |
| EPS Diluted Total Ops | 29.39 | 28.95 | 25.44 | 22.81 | 23.68 |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $N/A |